March 30, 2022 - Global Pharma Times

Sun Pharma to introduce its version of Vortioxetine in India under an exclusive patent license from Lundbeck

March 30, 2022March 30, 2022

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharma” and includes its subsidiaries and/or associate companies) today announced that...

BioBetter Breaks Bottleneck in Cultivated Meat with Tobacco Plants

Staff Reporter

March 30, 2022March 30, 2022

Kiryat Shemona, Israel - FoodTech start-up, BioBetter, Ltd., has assigned a new role for the much-maligned Nicotiana tabacum plant upon discovering it can overcome the...

Cold Sores during Winters & its prevention measure

Staff Reporter

March 30, 2022March 30, 2022

The author of this article is Dr. Gowri Kulkarni, Head of Medical Operations, MediBuddy Winters are wonderful for some, but they can be difficult for...

Breaking News

Apollo Hospitals leads the conversation on “Remote Critical Care” via an International Symposium

Bharat Rubber Works at PharmaPack 2022

MediBuddy launches #LabsFromHome

Neuberg Diagnostics joins hands with Bose Clinical Laboratory to mark its presence in Madurai

Medikabazaar conducts delivery of medical supplies through drone delivery

1.25-million-dollar US Air Force Commitment to Active Airmen wellbeing

Integrated Healthcare Platform, Eka Care, expands in Lucknow

Thalassemia Day Celebration by SRCC Children’s Hospital, Managed by Narayana Health

Colon cleansing: a brief insight attributed to Mr. Santosh Pandey, Diploma in Acupuncture, Acupuncturist

Narayana Health City in collaboration with the Thalassemia and Sickle Cell Society of Bangalore observed World Thalassemia Day

Sun Pharma to introduce its version of Vortioxetine in India under an exclusive patent license from Lundbeck

BioBetter Breaks Bottleneck in Cultivated Meat with Tobacco Plants

Cold Sores during Winters & its prevention measure